InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
61,539.03
(
1.22%
)
Post# of 6280
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Prudent Capitalist

Send PM Follow Ignore
Followers 135
Posts 17946
Boards Moderated 10
Alias Born 05/28/2009

Prudent Capitalist

Re: expediter13 post# 6051

Wednesday, 07/09/2014 5:36:27 PM

Wednesday, July 09, 2014 5:36:27 PM

Post# of 6280
Agreed. AVNR has several compounds in advances stages of trial, and Nuedexta's sales are growing rapidly. Great prospects here, and AVNR still trading well below analysts projections. not to mention the short interest and resulting potential for a significant short squeeze.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up